UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000038307
Receipt number R000043660
Scientific Title Characteristics and prognosis study of real-world cardiac amyloidosis
Date of disclosure of the study information 2019/11/01
Last modified on 2023/12/08 09:56:18

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Characteristics and prognosis study of
real-world cardiac amyloidosis

Acronym

CAPTURE-AMYLOID

Scientific Title

Characteristics and prognosis study of
real-world cardiac amyloidosis

Scientific Title:Acronym

CAPTURE-AMYLOID

Region

Japan


Condition

Condition

Cardiac amyloidosis

Classification by specialty

Cardiology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the characteristics of patients with cardiac amyloidosis

Basic objectives2

Others

Basic objectives -Others

To evaluate the prognosis of patients with cardiac amyloidosis

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

A composite of all-cause death and hospitalization for heart failure

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1. Patients who were diagnosed as cardiac amyloidosis after September 1, 2019
2. Patients in whom written informed consent was obtained

Key exclusion criteria

Patients in whom written informed consent was not obtained

Target sample size

100


Research contact person

Name of lead principal investigator

1st name Takao
Middle name
Last name Kato

Organization

Kyoto University Hospital

Division name

Department of Cardiovascular Medicine

Zip code

606-8507

Address

54 Shogoin-Kawahara-cho, Sakyo-ku, Kyoto 606-8507 Japan

TEL

075-751-4255

Email

tkato75@kuhp.kyoto-u.ac.jp


Public contact

Name of contact person

1st name Ryusuke
Middle name
Last name Nishikawa

Organization

Kyoto University Hospital

Division name

Department of Cardiovascular Medicine

Zip code

606-8507

Address

54 Shogoin-Kawahara-cho, Sakyo-ku, Kyoto 606-8507 Japan

TEL

075-751-4255

Homepage URL


Email

rn6072@kuhp.kyoto-u.ac.jp


Sponsor or person

Institute

Kyoto University Hospital

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Kyoto University Graduate School and Faculty of Medicine Kyoto University Hospital Ethics Committe

Address

Yoshidakonoe-cho, Sakyo-ku, Kyoto 606-8501 Japan

Tel

075-753-4680

Email

ethcom@kuhp.kyoto-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2019 Year 11 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

141

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2019 Year 10 Month 07 Day

Date of IRB

2019 Year 10 Month 07 Day

Anticipated trial start date

2019 Year 11 Month 01 Day

Last follow-up date

2024 Year 10 Month 07 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Prospective cohort study


Management information

Registered date

2019 Year 10 Month 16 Day

Last modified on

2023 Year 12 Month 08 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000043660


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name